المؤلفون: Valsalakumari R, Pandya AD, Prasmickaite L, Kvalvaag A, Myrann AG, Åslund AKO, Kjos MS, Fontecha-Cuenca C, Haroon HB, Ribeiro ARS, Horejs-Hoeck J, Moghimi SM, Mørch Ý, Skotland T, Sandvig K, Mælandsmo GM, Iversen TG

المصدر: International Journal of Nanomedicine, Vol Volume 19, Pp 3009-3029 (2024)

مصطلحات موضوعية: poly(alkyl cyanoacrylate), cabazitaxel, breast cancer, patient derived xenograft, tumor microenvironment, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/preclinical-efficacy-of-cabazitaxel-loaded-poly2-alkyl-cyanoacrylate-n-peer-reviewed-fulltext-article-IJN; https://doaj.org/toc/1178-2013

URL الوصول: https://doaj.org/article/f9b305b4d08d48099f5398ab30a8ec20

المؤلفون: Haugen, MH, Gythfeldt, HV, Egeland, EV, Normann, LS, Pandya, AD, Vedin, LL, Juell, S, Tenstad, E, Oy, GF, Kristian, A, Marangoni, E, Sorlie, T, Steffensen, K, Maelandsmo, GM, Engebraaten, O

المصدر: Molecular oncology. 17(10):2041-2055

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:153038830

المؤلفون: Pandya AD, Jäger E, Bagheri Fam S, Höcherl A, Jäger A, Sincari V, Nyström B, Štěpánek P, Skotland T, Sandvig K, Hrubý M, Mælandsmo GM

المصدر: International Journal of Nanomedicine, Vol Volume 14, Pp 6269-6285 (2019)

مصطلحات موضوعية: Reactive oxygen species, ROS-sensitive nanoparticles, Paclitaxel, Treatment efficacy, Macrophage infiltration, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/paclitaxel-loaded-biodegradable-ros-sensitive-nanoparticles-for-cancer-peer-reviewed-article-IJN; https://doaj.org/toc/1178-2013

URL الوصول: https://doaj.org/article/ae5a20d5062441a4968f7b39df48feca

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Fusser M; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Øverbye A; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Pandya AD; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Mørch Ý; Department of Biotechnology and Nanomedicine, SINTEF, AS, Trondheim, Norway., Borgos SE; Department of Biotechnology and Nanomedicine, SINTEF, AS, Trondheim, Norway., Kildal W; Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Snipstad S; Department of Biotechnology and Nanomedicine, SINTEF, AS, Trondheim, Norway; Department of Physics, The Norwegian University of Science and Technology, Trondheim, Norway., Sulheim E; Department of Biotechnology and Nanomedicine, SINTEF, AS, Trondheim, Norway; Department of Physics, The Norwegian University of Science and Technology, Trondheim, Norway., Fleten KG; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Askautrud HA; Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, The Medical Faculty, University of Oslo, Oslo, Norway., Flatmark K; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, The Medical Faculty, University of Oslo, Oslo, Norway., Iversen TG; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Sandvig K; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Department of Biosciences, University of Oslo, Oslo, Norway., Skotland T; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Electronic address: torsko@rr-research.no., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Department of Pharmacy, University of Tromsø, Tromsø, Norway.

المصدر: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 Sep; Vol. 349, pp. 1. Date of Electronic Publication: 2022 Jul 02.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Pandya AD; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Iversen TG; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Moestue S; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway., Grinde MT; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, 7491 Trondheim, Norway., Mørch Ý; SINTEF AS, Department of Biotechnology and Nanomedicine, 7034 Trondheim, Norway., Snipstad S; SINTEF AS, Department of Biotechnology and Nanomedicine, 7034 Trondheim, Norway.; Department of Physics, Norwegian University of Science and Technology, 7491 Trondheim, Norway.; Cancer Clinic, St. Olav's Hospital, 7030 Trondheim, Norway., Åslund AKO; SINTEF AS, Department of Biotechnology and Nanomedicine, 7034 Trondheim, Norway., Øy GF; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Engebråten O; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway.; Department of Oncology, Oslo University Hospital, 0450 Oslo, Norway.; Institute of Clinical Medicine, Medical Faculty, University of Oslo, 0315 Oslo, Norway., Sandvig K; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway.; Department of Biosciences, University of Oslo, 0315 Oslo, Norway., Skotland T; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379 Oslo, Norway.; Department of Medical Biology, University of Tromsø, 9019 Tromsø, Norway.

المصدر: Nanomaterials (Basel, Switzerland) [Nanomaterials (Basel)] 2021 Apr 28; Vol. 11 (5). Date of Electronic Publication: 2021 Apr 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101610216 Publication Model: Electronic Cited Medium: Print ISSN: 2079-4991 (Print) Linking ISSN: 20794991 NLM ISO Abbreviation: Nanomaterials (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Valsalakumari R; Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India., Yadava SK; Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India., Szwed M; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland., Pandya AD; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; Institute of Medical Biology, The Arctic University of Norway, University of Tromsø, Tromsø, Norway., Torgersen ML; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Iversen TG; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Skotland T; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Sandvig K; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; Department of Biosciences, University of Oslo, Oslo, Norway. Electronic address: ksandvig@radium.uio.no., Giri J; Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India. Electronic address: jgiri@bme.iith.ac.in.

المصدر: International journal of pharmaceutics [Int J Pharm] 2021 Mar 15; Vol. 597, pp. 120217. Date of Electronic Publication: 2021 Jan 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Nanocapsules*, Animals ; Cell Line, Tumor ; Female ; Humans ; Lipids ; Mice ; Paclitaxel ; Tissue Distribution